Global Cardiac Surgical Devices Market Size By Product (Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment), By Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease), By Geographic Scope And Forecast

Cardiac Surgical Devices Market Size And Forecast

Cardiac Surgical Devices Market size was valued at USD 28.6797 Billion in 2024 and is projected to reach USD 43.351 Billion by 2031, growing at a CAGR of 5.30% from 2024 to 2031.

Due to the rising frequency of heart disorders worldwide, there are cardiac operations performed, which subsequently raises the need for cardiac surgical equipment. Additionally, new chances for the market to expand with a higher CAGR may arise because of numerous technical developments in cardiac surgical equipment. The Global Cardiac Surgical Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cardiac Surgical Devices Market Definition

Heart disease and other medical disorders are detected and treated with the use of cardiac surgical Devices. Heart surgeons must conduct cardiac surgery to treat heart difficulties or illnesses such as congenital heart disease, valvular heart disease, and ischemic heart disease. The term “cardiac surgical device” refers to any surgical operation involving the heart or a blood artery and the use of equipment. Cardiopulmonary bypass equipment, disposables for perfusion, cardiac ablation tools, and beating heart surgery systems are a few examples of surgical instruments. Due to the rising frequency of heart disorders worldwide, there are cardiac operations performed, which subsequently raises the need for cardiac surgery instruments.

A therapy used to treat cardiac arrhythmias is catheter ablation. With the availability of a wide range of catheter ablation products from Medtronic, it is anticipated that demand for cardiac surgical devices will grow in the years to come as atrial fibrillation rates rise. In the market for cardiac surgical devices, there are a number of significant companies. Boston Scientific Corporation, Medtronic’s Inc. and Abbott Laboratories are a few of the key players in the industry. Leading companies like Medtronic and Getinge are developing innovative beating heart surgery solutions that make it simpler for surgeons to perform surgery even while the heartbeat is still beating.

Global Cardiac Surgical Devices Market Overview

The main drivers of the worldwide demand for cardiovascular surgical devices are the growing incidence of cardiovascular illnesses and the aging population. In addition, it is expected that rising sedentary lifestyles, co-morbidities, excessive cigarette use, diabetes, and an increase in the number of obese individuals would drive the worldwide market for cardiovascular surgical devices. Additionally, new developments in medical device technology are boosting the industry’s expansion.

For instance, the development of a suture-less big bore closure device is predicted to increase the worldwide market for cardiovascular surgical devices. Nevertheless is projected that the expansion of the cardiovascular surgical devices market would be slowed during the forecast period due to cost restrictions connected with these devices and a shortage of experienced experts in underdeveloped and emerging countries of the world. Furthermore, the market for cardiac surgical equipment has been restrained by a rise in the use of alternative surgical technology, which has led to a decline in the use of traditional surgical techniques.

The market for cardiac surgical devices may have new growth prospects with a higher CAGR as a result of numerous technological developments. For instance, Abbott India introduced a gadget in 2021 to repair congenital cardiac abnormalities in preterm infants. The smallest newborns (weighing as low as 700 gms) can have the Amplatzer Piccolo, the world’s first medical device, implanted utilizing a minimally invasive method to treat patent ductus arteriosus (PDA). One-fifth of the 240,000 infants born in India had congenital cardiac abnormalities

The Global Cardiac Surgical Devices Market Segmentation Analysis

The Global Cardiac Surgical Devices Market is segmented based on Product, Application, and Geography.

Cardiac Surgical Devices Market, By Product

• Cardiopulmonary Bypass Equipment
• Perfusion Disposables
• Beating Heart Surgery Systems
• Cardiac Ablation Devices

Based on Product, the market is bifurcated into Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, and Perfusion Disposables. The Cardiopulmonary Bypass Equipment segment accounted for the largest market share in 2022 and is projected to grow at a significant CAGR during the forecast period. With a machine, the heart and lungs are briefly replaced following surgery so that the patient’s body may continue to circulate blood and absorb oxygen. Producers of significant cardiopulmonary bypass machines include Medtronic, Sorin, and Terumo. The demand for cardiopulmonary bypass equipment is anticipated to rise in the next years due to an increase in medical device firms’ R&D in producing cutting-edge cardiopulmonary products and an increase in the prevalence of cardiovascular disorders.

Cardiac Surgical Devices Market, By Application

• Coronary Heart Disease
• Cardiac Arrhythmia
• Congenital Heart Defects
• Congestive Heart Failure

Based on Application, the Market is segmented into congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure. The Coronary Heart Disease segment accounted for the largest market share in 2022 and is projected to grow at the highest CAGR during the forecast period. The most prevalent kind of heart disease in America, coronary artery disease affects million adult Americans, according to the Centers for Disease Control and Prevention. It is the most prevalent kind of heart disease in the US and a major cause of mortality in the UK. Since surgery is required to address this disorder, it is projected that growth would be aided by the disease’s rising occurrence.

Cardiac Surgical Devices Market, By Geography

• North America
• Europe
•  Asia Pacific
• Middle East and Africa
• Latin America

Based on regional analysis, the Global Cardiac Surgical Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the largest market share and is projected to grow at a significant CAGR during the forecast period. Due to a larger penetration of technologically advanced medical equipment in the area, particularly in the United States, North America has a prominent position. In the US, numerous open heart procedures are carried out annually. Additionally, there are businesses in the US that provide a wide range of cardiac surgery instruments.

Key Players

The “Global Cardiac Surgical Devices Market” study report will provide valuable insight with an emphasis on the global market including The major players in the market are; Getinge Group, Atrion Corporation, Johnson & Johnson, Abbott Laboratories, Sorin S.P.A. (Livanova), Medtronic, Boston Scientific Corporation, Edwards Life Science Corporation, Terumo Medical Corporation, Cook Medical. among others. This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In 2022, To increase the variety of cardiac ablation procedures it offers, Medtronic purchased Boston-based medical device manufacturer Affera Inc. Affera develops and produces catheter-based cardiac ablation technologies as well as electrophysiology (EP) cardiac mapping and navigation devices. To increase the variety of cardiac ablation procedures it offers, Medtronic purchased Boston-based medical device manufacturer Affera Inc. Affera develops and produces catheter-based cardiac ablation technologies as well as electrophysiology (EP) cardiac mapping and navigation devices.
• In June 2021, Boston Scientific Exercises Option to Acquire Farapulse, Inc., Acquisition complements the company’s electrophysiology portfolio to include the only commercially available cardiac pulsed-field ablation technology.
• In 2020, Boston Scientific Corporation signed an investment agreement with an exclusive option to acquire Farapulse, Inc., a privately held company developing a pulsed field ablation (PFA) system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Cardiac Surgical Devices Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Cardiac Surgical Devices Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Research Methodology of Market Research